Boston Scientific Corp (XTER:BSX)
€ 86.5 -0.5 (-0.57%) Market Cap: 126.52 Bil Enterprise Value: 134.81 Bil PE Ratio: 74.93 PB Ratio: 6.45 GF Score: 79/100

Boston Scientific Corp at Evercore HealthCONx Conference Transcript

Dec 04, 2019 / 04:00PM GMT
Vijay Muniyappa Kumar
Evercore ISI Institutional Equities, Research Division - MD

Okay. I think we'll get started here. Thanks everyone for joining us this morning. Vijay Kumar, I cover devices and tools at Evercore. Happy to have with us, Boston Scientific, in their backyard. We have representing the company, Susie Lisa; and Lauren Tengler from the IR team. Susie, Lauren, welcome and thank you for participating.

Susan Vissers Lisa
Boston Scientific Corporation - VP of IR

Thank you.

Lauren Tengler
Boston Scientific Corporation - Director of IR

Thank you.

Questions & Answers

Vijay Muniyappa Kumar
Evercore ISI Institutional Equities, Research Division - MD

So I guess just maybe starting with what happened in 3Q. I mean organic came in really, really strong. I thought, even ex the extra selling days, organic came in really, really strong. Maybe -- was there anything that surprised you guys? I know you guys said all this -- the guidance that's baked in this

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot